Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
The Expanding Paramedicine in the Community (Study)
Initiatives aimed at reducing Emergency Department (ED) wait times and improved community
health initiatives are major priorities in Canada. Three of the most common chronic diseases
worldwide are Diabetes Mellitus (DM), Congestive Heart Failure (CHF) and Chronic Obstructive
Pulmonary Disease (COPD). These diseases are on the rise and currently cost the Canadian
health care system billions of dollars every year including the cost of hospitalizations and
ED visits. The existing health care system does not have the resources and manpower to
effectively care for these patients in the future.
Paramedics are currently employed to provide Emergency Medical Services in remote, rural and
urban settings in Canada.
They are highly trained health care practitioners that are mobile in the community and
currently work in a physician medically delegated act model and therefore are positioned to
take on new collaborative roles to deliver patient care in the community setting. Increased
community paramedic care could decrease the utilization of the health care system resources
for patients with chronic disease. Using a randomized control trial design we will attempt to
answer the question of whether whether non-emergency community paramedics conducting home
visits to undertake assessments and evidence-based treatments of patients in partnership with
family doctors will decrease the rate of patient hospitalization.
Imagine if we could leverage existing infrastructure to enhance how we better manage and
support patients with chronic disease in the community? Three of the most common chronic
diseases worldwide are Diabetes Mellitus (DM), Congestive Heart Failure (CHF) and Chronic
Obstructive Pulmonary Disease (COPD). These diseases are on the rise and currently cost the
Canadian health care system billions of dollars every year including the cost of unnecessary
hospitalizations and ED visits. The current structure of the health care system does not have
the capacity to effectively care for these patients in the future. Paramedics are currently
employed 24-7 to provide Emergency Medical Services (EMS) in urban, rural and settings across
Canada. They are highly trained health care practitioners that are connected to and mobile in
the community and currently work in a medically delegated act model with physicians where
they regularly rely on independent judgment giving them a significant advantage in assessing
patients. The evidence already tells us that collaborative Chronic Care Models can improve
patient outcomes and decrease overall health care utilization. What if we leveraged this
incredible resource to enhance patient care in the community setting? We hypothesize that
training paramedics in chronic disease management and having them conduct home visits to
assess and treat patients under medical delegation of the patients' primary care physicians
will reduce the rate of acute care hospitalization and, ED visits, EMS utilization, and
Family Health Team (FHT) utilization for COPD, DM and CHF patients.
So how do we find out if it works? We propose a randomized controlled trial (Level 1
evidence) to rigorously study the effectiveness of community paramedicine model versus
standard care. The primary study question is whether non-emergency community paramedics
conducting home visits to undertake assessments and evidence-based treatments of patients
under the medical delegation of primary care physicians will decrease the rate of
hospitalization for chronic disease patients. Our intervention will be applied in select
Ontario Family Health Team (FHT) patients diagnosed with COPD, CHF and DM. We plan to
randomize 695 patients: patients randomized to the intervention group will be assessed and
treated during home visits by community paramedics. Patients randomized to the control group
will continue to receive usual care from the participating Family Health Teams. The number of
hospitalizations, hospital length of stay, ED visits, EMS utilization and cost-effectiveness
will be compared using existing administrative databases. We have been doing a feasibility
trial since March of 2013 to confirm our recruitment and data collection approaches.
The intent of the Partnerships for Health System Improvement (PHSI) program is to strengthen
Canada's health care system through collaborative, applied and policy-relevant research. Our
project has been developed in strong partnership with Centennial College; Central Community
Care Access Centre; York Region Emergency Medical Services; Health For All Family Health
Team; Markham Family Health Team; Rescu, Li Ka Shing Knowledge Institute, St. Michael's
Hospital; and the Sunnybrook Centre for Prehospital Medicine. We have also partnered directly
with the Primary Care Branch of the Ministry of Health and Long Term Care to ensure a
fruitful integrated knowledge translation plan at the policy level. By engaging all of the
key stakeholders upfront we have already created the necessary linkages to make this health
system innovation possible.
If found to be effective, the simplicity of the community paramedicine model allows it to be
scalable in various ways for EMS services across the country. It could also be expanded to
include management of several other conditions. Funding is only getting tighter and health
care capacities will be increasingly challenged in the coming years - innovation in how we
use existing resources is the future of health system improvement. Community paramedicine is
a perfect example of this type of innovation and our project will provide the evidence needed
by decision makers and knowledge users to significantly impact primary care policy making for
the future.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
Withdrawn |
NCT01377428 -
Efficacy of Indacaterol 150 µg Versus Formoterol
|
Phase 4 |